Replies to post #46737 on Biotech Values

[DewDiligence]

>MODG has just found a particular CTP that confers stability to proteins, so they'll produce CTP-modified proteins as an alternative to , say, PEGylated proteins.<

What do you see as the pros and cons of the CTP approach relative to the PEGylation approach for producing next-generation versions of protein drugs? Is there enough information in the public domain to speculate? T.i.a. Dew

[DewDiligence]

Re: Carboxyl terminal peptide (CTP) approach to extended half-life

>since all proteins already have a carboxyl terminal peptide , so it makes you wonder why they need another.<

MODG just held its first-ever webcast; it contained some layperson color on why this approach is used. Regards, Dew